Literature DB >> 7958871

The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site.

P Champion-Arnaud1, R Reed.   

Abstract

The mammalian spliceosome-associated protein, SAP 49, is associated specifically with U2 snRNP and is the most efficiently UV cross-linked protein in the spliceosomal complexes A, B, and C. We show here that SAP 49 cross-links to a region in the pre-mRNA immediately upstream of the branchpoint sequence in the prespliceosomal complex A. In addition to the RNA-binding activity of SAP 49, we show that this protein interacts directly and highly specifically with another U2 snRNP-associated spliceosomal protein, SAP 145. We have isolated a cDNA-encoding SAP 49 and find that it contains two amino-terminal RNA-recognition motifs (RRMs), consistent with the observation that SAP 49 binds directly to pre-mRNA. The remainder of the protein is highly proline-glycine rich (39% proline and 17% glycine). Unexpectedly, the SAP 49-SAP 145 protein-protein interaction requires the amino-terminus of SAP 49 that contains the two RRMs. The observation that SAP 49 and SAP 145 interact directly with both U2 snRNP and the pre-mRNA suggests that this protein complex plays a role in tethering U2 snRNP to the branch site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958871     DOI: 10.1101/gad.8.16.1974

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  48 in total

1.  Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.

Authors:  P Ajuh; B Kuster; K Panov; J C Zomerdijk; M Mann; A I Lamond
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

2.  Domains in human splicing factors SF3a60 and SF3a66 required for binding to SF3a120, assembly of the 17S U2 snRNP, and prespliceosome formation.

Authors:  D Nesic; A Krämer
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.

Authors:  Yasuhiko Terada; Yuko Yasuda
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

4.  Rearrangement of competing U2 RNA helices within the spliceosome promotes multiple steps in splicing.

Authors:  Rhonda J Perriman; Manuel Ares
Journal:  Genes Dev       Date:  2007-04-01       Impact factor: 11.361

5.  SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.

Authors:  Andrew Dauber; Christelle Golzio; Cécile Guenot; Francine M Jodelka; Maria Kibaek; Susanne Kjaergaard; Bruno Leheup; Danielle Martinet; Malgorzata J M Nowaczyk; Jill A Rosenfeld; Susan Zeesman; Janice Zunich; Jacques S Beckmann; Joel N Hirschhorn; Michelle L Hastings; Sebastien Jacquemont; Nicholas Katsanis
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

Review 6.  Facial dysostoses: Etiology, pathogenesis and management.

Authors:  Paul A Trainor; Brian T Andrews
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

7.  CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.

Authors:  D Yan; R Perriman; H Igel; K J Howe; M Neville; M Ares
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Association of RB97D, an RRM protein required for male fertility, with a Y chromosome lampbrush loop in Drosophila spermatocytes.

Authors:  V M Heatwole; S R Haynes
Journal:  Chromosoma       Date:  1996-12       Impact factor: 4.316

9.  Comprehensive proteomic analysis of nonintegrin laminin receptor interacting proteins.

Authors:  Lisa Venticinque; Daniel Meruelo
Journal:  J Proteome Res       Date:  2012-08-29       Impact factor: 4.466

10.  U2 snRNA-protein contacts in purified human 17S U2 snRNPs and in spliceosomal A and B complexes.

Authors:  Olexandr Dybkov; Cindy L Will; Jochen Deckert; Nastaran Behzadnia; Klaus Hartmuth; Reinhard Lührmann
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.